US20060062861A1 - Novel anti-irritant botanicals - Google Patents
Novel anti-irritant botanicals Download PDFInfo
- Publication number
- US20060062861A1 US20060062861A1 US11/183,495 US18349505A US2006062861A1 US 20060062861 A1 US20060062861 A1 US 20060062861A1 US 18349505 A US18349505 A US 18349505A US 2006062861 A1 US2006062861 A1 US 2006062861A1
- Authority
- US
- United States
- Prior art keywords
- irritant
- extracts
- extract
- skin
- leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002085 irritant Substances 0.000 title claims abstract description 78
- 239000000284 extract Substances 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 18
- 210000003491 skin Anatomy 0.000 claims description 37
- 230000003078 antioxidant effect Effects 0.000 claims description 35
- 241000196324 Embryophyta Species 0.000 claims description 33
- 239000003963 antioxidant agent Substances 0.000 claims description 31
- 235000006708 antioxidants Nutrition 0.000 claims description 31
- 240000008042 Zea mays Species 0.000 claims description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 18
- 235000005822 corn Nutrition 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 15
- 230000003305 autocrine Effects 0.000 claims description 14
- 239000000399 hydroalcoholic extract Substances 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 210000002510 keratinocyte Anatomy 0.000 claims description 11
- 235000021028 berry Nutrition 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 10
- 244000269722 Thea sinensis Species 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 244000025221 Humulus lupulus Species 0.000 claims description 8
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 7
- 241000218922 Magnoliophyta Species 0.000 claims description 7
- 238000003556 assay Methods 0.000 claims description 7
- 230000009668 clonal growth Effects 0.000 claims description 7
- 235000012661 lycopene Nutrition 0.000 claims description 7
- 150000004492 retinoid derivatives Chemical class 0.000 claims description 7
- 244000299461 Theobroma cacao Species 0.000 claims description 6
- 239000007800 oxidant agent Substances 0.000 claims description 6
- 230000037380 skin damage Effects 0.000 claims description 6
- 235000015113 tomato pastes and purées Nutrition 0.000 claims description 6
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- 244000178870 Lavandula angustifolia Species 0.000 claims description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 4
- 240000007313 Tilia cordata Species 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 4
- 239000001102 lavandula vera Substances 0.000 claims description 4
- 235000018219 lavender Nutrition 0.000 claims description 4
- 238000000464 low-speed centrifugation Methods 0.000 claims description 4
- 239000001751 lycopene Substances 0.000 claims description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 4
- 229960004999 lycopene Drugs 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 4
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 3
- 244000000626 Daucus carota Species 0.000 claims description 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 3
- 241000219094 Vitaceae Species 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 235000021021 grapes Nutrition 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 210000000434 stratum corneum Anatomy 0.000 claims description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 2
- 235000021538 Chard Nutrition 0.000 claims description 2
- 240000005183 Lantana involucrata Species 0.000 claims description 2
- 235000013628 Lantana involucrata Nutrition 0.000 claims description 2
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 claims description 2
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 2
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 2
- 235000004634 cranberry Nutrition 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 239000003617 indole-3-acetic acid Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 230000007613 environmental effect Effects 0.000 claims 4
- 244000080208 Canella winterana Species 0.000 claims 2
- 235000008499 Canella winterana Nutrition 0.000 claims 2
- 240000000560 Citrus x paradisi Species 0.000 claims 2
- 229940017545 cinnamon bark Drugs 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 238000011146 sterile filtration Methods 0.000 claims 2
- 235000007630 Elaeagnus umbellata var parvifolia Nutrition 0.000 claims 1
- 244000138900 Elaeagnus umbellata var. parvifolia Species 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 244000305267 Quercus macrolepis Species 0.000 claims 1
- 241000219053 Rumex Species 0.000 claims 1
- 235000015422 Rumex crispus ssp. crispus Nutrition 0.000 claims 1
- 235000015426 Rumex crispus ssp. fauriei Nutrition 0.000 claims 1
- 244000207667 Rumex vesicarius Species 0.000 claims 1
- 244000204900 Talipariti tiliaceum Species 0.000 claims 1
- 235000006468 Thea sinensis Nutrition 0.000 claims 1
- 240000001717 Vaccinium macrocarpon Species 0.000 claims 1
- 239000000039 congener Substances 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 239000000122 growth hormone Substances 0.000 claims 1
- 235000014571 nuts Nutrition 0.000 claims 1
- 230000008635 plant growth Effects 0.000 claims 1
- 235000012424 soybean oil Nutrition 0.000 claims 1
- 239000003549 soybean oil Substances 0.000 claims 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 claims 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 claims 1
- 231100000021 irritant Toxicity 0.000 abstract description 13
- 206010040880 Skin irritation Diseases 0.000 abstract description 11
- 230000036556 skin irritation Effects 0.000 abstract description 11
- 231100000475 skin irritation Toxicity 0.000 abstract description 11
- 239000004615 ingredient Substances 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 239000005414 inactive ingredient Substances 0.000 abstract description 2
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 25
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 229960000686 benzalkonium chloride Drugs 0.000 description 12
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 12
- 150000008442 polyphenolic compounds Chemical class 0.000 description 10
- 230000000699 topical effect Effects 0.000 description 10
- 229930003935 flavonoid Natural products 0.000 description 9
- 150000002215 flavonoids Chemical class 0.000 description 9
- 235000017173 flavonoids Nutrition 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 235000013824 polyphenols Nutrition 0.000 description 9
- 235000019165 vitamin E Nutrition 0.000 description 9
- 239000011709 vitamin E Substances 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- GMGIWEZSKCNYSW-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;dihydrate Chemical compound O.O.C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 GMGIWEZSKCNYSW-UHFFFAOYSA-N 0.000 description 7
- 241000219492 Quercus Species 0.000 description 7
- 229930003427 Vitamin E Natural products 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- -1 green tea leaves Chemical class 0.000 description 7
- 229940046009 vitamin E Drugs 0.000 description 7
- 206010070834 Sensitisation Diseases 0.000 description 6
- NAXKFVIRJICPAO-LHNWDKRHSA-N [(1R,3S,4R,6R,7R,9S,10S,12R,13S,15S,16R,18S,19S,21S,22S,24S,25S,27S,28R,30R,31R,33S,34S,36R,37R,39R,40S,42R,44R,46S,48S,50R,52S,54S,56S)-46,48,50,52,54,56-hexakis(hydroxymethyl)-2,8,14,20,26,32,38,43,45,47,49,51,53,55-tetradecaoxa-5,11,17,23,29,35,41-heptathiapentadecacyclo[37.3.2.23,7.29,13.215,19.221,25.227,31.233,37.04,6.010,12.016,18.022,24.028,30.034,36.040,42]hexapentacontan-44-yl]methanol Chemical compound OC[C@H]1O[C@H]2O[C@H]3[C@H](CO)O[C@H](O[C@H]4[C@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]6[C@H](CO)O[C@H](O[C@H]7[C@H](CO)O[C@@H](O[C@H]8[C@H](CO)O[C@@H](O[C@@H]1[C@@H]1S[C@@H]21)[C@@H]1S[C@H]81)[C@H]1S[C@@H]71)[C@H]1S[C@H]61)[C@H]1S[C@@H]51)[C@H]1S[C@@H]41)[C@H]1S[C@H]31 NAXKFVIRJICPAO-LHNWDKRHSA-N 0.000 description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 230000037067 skin hydration Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 4
- 108010009202 Growth Factor Receptors Proteins 0.000 description 4
- 102000009465 Growth Factor Receptors Human genes 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000017803 cinnamon Nutrition 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000000622 irritating effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical compound OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 229930002330 retinoic acid Natural products 0.000 description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical group CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 4
- 239000004017 serum-free culture medium Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 229960001727 tretinoin Drugs 0.000 description 4
- 244000291564 Allium cepa Species 0.000 description 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 3
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- 241001057636 Dracaena deremensis Species 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- AVOLMBLBETYQHX-UHFFFAOYSA-N etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 3
- 229960003199 etacrynic acid Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000002664 lycopenes Chemical class 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000012254 powdered material Substances 0.000 description 3
- 230000001235 sensitizing effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 235000017336 Capparis spinosa Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- UBJVUCKUDDKUJF-UHFFFAOYSA-N Diallyl sulfide Chemical compound C=CCSCC=C UBJVUCKUDDKUJF-UHFFFAOYSA-N 0.000 description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- 101800003838 Epidermal growth factor Proteins 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- 102000018710 Heparin-binding EGF-like Growth Factor Human genes 0.000 description 2
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 2
- 240000000950 Hippophae rhamnoides Species 0.000 description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical group OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 2
- 241000907897 Tilia Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940116977 epidermal growth factor Drugs 0.000 description 2
- 230000036566 epidermal hyperplasia Effects 0.000 description 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229930186179 lupulin Natural products 0.000 description 2
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229960004255 nadolol Drugs 0.000 description 2
- VWPOSFSPZNDTMJ-UCWKZMIHSA-N nadolol Chemical compound C1[C@@H](O)[C@@H](O)CC2=C1C=CC=C2OCC(O)CNC(C)(C)C VWPOSFSPZNDTMJ-UCWKZMIHSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 2
- 235000017700 silymarin Nutrition 0.000 description 2
- 229960004245 silymarin Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012358 sourcing Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- QGVLYPPODPLXMB-UBTYZVCOSA-N (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-5H-cyclopropa[3,4]benzo[1,2-e]azulen-5-one Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)[C@@H](O)[C@@]3(O)C(C)(C)[C@H]3[C@@H]21 QGVLYPPODPLXMB-UBTYZVCOSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical group O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- COAWNPJQKJEHPG-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1lambda^{4}-chromen-1-ylium chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 COAWNPJQKJEHPG-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QHMQAWNNHVPBQU-UHFFFAOYSA-N 3-(2-hydroxy-3-methylphenyl)-1-phenylprop-2-en-1-one Chemical compound CC1=CC=CC(C=CC(=O)C=2C=CC=CC=2)=C1O QHMQAWNNHVPBQU-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- BJEMXPVDXFSROA-UHFFFAOYSA-N 3-butylbenzene-1,2-diol Chemical group CCCCC1=CC=CC(O)=C1O BJEMXPVDXFSROA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- 241000873224 Capparaceae Species 0.000 description 1
- 244000140995 Capparis spinosa Species 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 241001634496 Cola nitida Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001648652 Croton ovalifolius Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000018274 Cunila origanoides Nutrition 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 244000182625 Dictamnus albus Species 0.000 description 1
- 235000014866 Dictamnus albus Nutrition 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 244000148687 Glycosmis pentaphylla Species 0.000 description 1
- 235000019500 Grapefruit seed oil Nutrition 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 description 1
- QTDMGAWIBXJNRR-UHFFFAOYSA-N Mangostin Natural products CC(=CCc1c(O)cc2Oc3cc(C)c(O)c(CC=C(C)C)c3C(=O)c2c1O)C QTDMGAWIBXJNRR-UHFFFAOYSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 235000014150 Myroxylon pereirae Nutrition 0.000 description 1
- 244000302151 Myroxylon pereirae Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- ZNXZGRMVNNHPCA-UHFFFAOYSA-N Pantetheine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000011111 UV-scan method Methods 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- GNRIZKKCNOBBMO-UHFFFAOYSA-N alpha-mangostin Chemical compound OC1=C(CC=C(C)C)C(O)=C2C(=O)C3=C(CC=C(C)C)C(OC)=C(O)C=C3OC2=C1 GNRIZKKCNOBBMO-UHFFFAOYSA-N 0.000 description 1
- 235000019286 ammonium lactate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 238000011208 chromatographic data Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- LOIYMIARKYCTBW-UPHRSURJSA-N cis-urocanic acid Chemical compound OC(=O)\C=C/C1=CNC=N1 LOIYMIARKYCTBW-UPHRSURJSA-N 0.000 description 1
- 239000010374 citricidal Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003112 degranulating effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- FVCOIAYSJZGECG-UHFFFAOYSA-N diethylhydroxylamine Chemical group CCN(O)CC FVCOIAYSJZGECG-UHFFFAOYSA-N 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- ADYPXRFPBQGGAH-UMYZUSPBSA-N dihydroergotamine mesylate Chemical compound CS(O)(=O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC=C(C=34)C2)C1)C)C1=CC=CC=C1 ADYPXRFPBQGGAH-UMYZUSPBSA-N 0.000 description 1
- 229960000807 dihydroergotamine mesylate Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003107 drug analog Substances 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940005608 hypericin Drugs 0.000 description 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 1
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000002973 irritant agent Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
- 229940043357 mangiferin Drugs 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- BZCKRPHEZOHHBK-UHFFFAOYSA-N methyl 2-phenoxyacetate Chemical compound COC(=O)COC1=CC=CC=C1 BZCKRPHEZOHHBK-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 231100000067 mild irritant Toxicity 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- RFWGABANNQMHMZ-ZCHJGGQASA-N oleuropein Chemical compound O([C@@H]\1OC=C([C@H](C/1=C\C)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-ZCHJGGQASA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229960001528 oxymetazoline Drugs 0.000 description 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- QGVLYPPODPLXMB-QXYKVGAMSA-N phorbol Natural products C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@H]3C=C(CO)C[C@@]4(O)[C@H](C=C(C)C4=O)[C@@]13O)C2(C)C QGVLYPPODPLXMB-QXYKVGAMSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 229930000184 phytotoxin Natural products 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000017363 positive regulation of growth Effects 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000026267 regulation of growth Effects 0.000 description 1
- 239000012261 resinous substance Substances 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- LBTVHXHERHESKG-UHFFFAOYSA-N tetrahydrocurcumin Chemical compound C1=C(O)C(OC)=CC(CCC(=O)CC(=O)CCC=2C=C(OC)C(O)=CC=2)=C1 LBTVHXHERHESKG-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Definitions
- the technical field of the invention is in the area of manufacture of topical ingredients for skin and wound care. More especially in the processing and formulation of ingredients developed from natural products, which possess anti-irritant and/or free radical scavenging antioxidant properties.
- fibers that are fibers
- an immune suppressant such as a composition that blocks CD1d activation
- U.S. Patent Appl., 20020165170A1 discloses a method that blocks antigen presentation by skin located immune cells.
- Lacharriere et al. have proposed the use of a histamine antagonist and or a TNF-alpha antagonist (Lacharriere, O. De; et al., 2001 in U.S. Appl., No.: 20010022978A1).
- Ethacrynic acid (Edacrinn, Merck) was effective in preventing contact sensitization due to the delivery to mouse skin of four sensitizing drugs: Clonidine, Chlorpheniramine, Albuterol, and Nadolol.
- Ethacrynic acid, a potassium ion channel blocker was also effective in preventing skin irritation due to the topical application to mouse of 2,4-dinitro-chlorobenzene, arachidonic acid, phorbol myristic acid, trans-retinoic acid, and lactic acid.
- the calcium ion channel blockers Nifedipine and Verapamil were effective in minimize contact sensitization in mouse skin due to topical application of the sensitizing and transdermally delivered drug, Nadolol.
- Phenoxyacetic acid and its alkyl derivatives, non-drug analogs of the diuretic, ethacrynic acid were shown to prevent contact sensitization due to application to mouse skin of the sensitizing hair dye, para-phenylenediamine and to block skin irritation due a panel of known skin irritants, including anionic surfactants such as sodium lauryl sulfate.
- agents which induce mast cell degranulation such as cis-urocanic acid and capsaicin were reported to prevent contact sensitization in a mouse skin model.
- flavonoids are known to be potent anti-oxidants. Topical replacement of skin anti-oxidants may help to alleviate damage due to ultraviolet radiation and ozone exposure. Flavonoids require stabilization against oxidation by addition of co-reductants such as Vitamin E ( ⁇ -tocopherol) or Vitamin C (Ascorbic Acid). No mechanism exists to reduce oxidized Vitamin E since there is no Ascorbic acid in the upper layers of the epidermis (stratum corneum). Lazendorfer et al., (2002) in U.S. Pat. No. 6,423,747 discloses cosmetic and dermatological preparations with favonoids having anti-oxidant properties. Illustrative examples mention standard water-in-oil and oil-in-water formations without providing any evidence of their efficacy in these formulations.
- flavonoids are among the plant-derived anti-irritants that are readily formulated in the novel hydrophobic delivery system claimed in this patent. They include many plants and herbs are rich in flavonoids as well as flavonoids present in Spanish Honeybee pollen.
- rutin, quercetin, myricetin, and trans-cinnamic acid were present at >350 mg/100 g.
- Kaempferol is the major flavonoid derived from lyophilized extracts of the flowering buds of capers ( Capparis spinosa L). This material was shown to have both anti-oxidant and photo-protective effects in human skin.
- Antioxidants and free radical scavengers have been employed in many patented formulations for eliminating or minimizing irritation and contact sensitization reactions.
- Inhivbitors of the metabolites of the arachidonic acid cascade known to be involved in the irritant mechanism of skin have been claimed in European Pat. No. EP 0,314,528A1.
- Among the designated anti-irritants claimed were Vitamin E, BHT, para-tertiary butyl catechol, hydroquinone, benzoquinone, N,N-diethylhydroxyamine, and nordihydroguaiareic acid.
- Vitamin C (ascorbic acid), a water soluble antioxidant, was disclosed in U.S. Pat. No. 5,516,793 to be effective in decreasing skin irritation caused by topical application of such ingredients as: a-hydroxy acids, benzoyl peroxide, retinal, retinoic acid, quaternary ammonium lactates, and salicylic acid.
- Vitamin E (a-tocopherol) is disclosed in U.S. Pat. No. 5,545,407 to reduce skin irritation caused by actives in dermatological preparations containing benzoyl peroxide., and in U.S. Pat. No. 5,252,604 it was disclosed that topical ⁇ -tocopherol reduced skin irritation due to repeated doses of retinoic acid.
- Another antioxidant panthenol and its derivatives pantothenic acid, pantethine and pantetheine have been claimed as anti-irritants for formulations containing up to 20% benzoyl peroxide.
- antioxidants in protecting the skin from harmful solar exposure, and photoaging are well known.
- Oxidants and Antioxidant in Cutaneous Biology Thiele and Elsner (2001) have assembled a comprehensive review of free radical chemistry in the skin and the antioxidant network of defense in the stratum corneum.
- antioxidants discussed for protection of skin are Vitamins E and Vitamin C, green tea polyphenols, resveratol, curcumin, silymarin, ginger, and diallyl sulfide, all of which afford some protection against the development of skin cancer.
- carotenoids lycopenes, luein and ⁇ , and ⁇ -carotene
- the protective effect of topical anti-oxidants against solar radiation result from e.g.: Vitamin E and Vitamin C.
- Other reported antioxidants that efficiently reduce photodamage include the thiol, N-acetylcysteine and ⁇ -lipoic acid, which may prevent oxidative stress in skin.
- plant-derived flavonoids apigerneic genistein, catechin, epicatechin, a-glycosylrutin and silymarin are polyphenols with good antioxidant activity.
- Vitamins C and E are routinely used as antioxidants to either stabilize cosmetic ingredients or more recently for their anti-aging free-radical scavenging properties.
- the most widely used botanical with accepted anti-irritant activity are is Aloe gel; and Witch Hazel (Hammelis Water) containing polymeric proanthocyanidins is by far the best documented case of a botanical anti-irritant.
- Other botanically-derived actives with potential anti-irritant activity are the catechins and polyphenols, e.g., green tea leaves, and grape seed oil extracts.
- Additional antioxidants derived from botanicals are Bisabolol, Epigallocatechine, Epigallocatechinegallate Rutin, Quercetin, Hesperidin, Diomine, Mangiferin, Mangostin, Cyanidin chloride, Astaxanthin, Xanthophylls, Lycopene, Reversatrol, Tetrahydrodiferuloylmethane, Rosmarinic acid, Hypericin, Ellagic acid, Chlorogenic acid, Oleoeuropein, Thiotic acid, Glutathione, and Andrographolide (Gupta, 2001). Few of these have been rigorously shown to have anti-irritant activity. Nevertheless, the prospects for broadening the base of plant derived anti-irritants is tremendous because only a small fraction of the over 250,000 known Angiosperm species has been explored.
- the natural botanical anti-irritants disclosed herein can be topically applied to skin in a formulation without an irritant for the purpose of preventing skin damage due to solar exposure or to oxidant type pollutants in the environment.
- TRK phosophotyrosine kinase
- the methods developed for preparing novel anti-irritant botanicals involves two steps, the sourcing and harvesting of plant materials and a novel processing methods.
- the aroma of plants may be used as a to guide to possible sources of new botanicals.
- certain phenoxy acids and benzoic acid derivatives have a peculiarly pungent smell.
- the inventor has previously disclosed that phenoxyacetic acid esters are in fact anti-irritants in U.S. Pat. No. 6,670,395(2003).
- the Inventor has relied primarily on his sense of smell to detect and source many novel anti-irritant plants.
- Another source of botanicals with potential anti-oxidant and anti-irritant properties are edible plant fruiting bodies; in particular, the ripe red edible berries of Autumn Olive ( Eleagnus umbellate ) trees, and the orange berries of Sea Buckthorn ( Hippophae rhanmoides ), a closely related member of the Eleagnacae family.
- Green tea leaves are rich in methyl xanthenes (caffeine, theophylline) and antioxidant polyphenols including catchins, and epigallocatechins. They have been the subject of much recent work on topical and dietary use to prevent cancer, and photodamage by exposure to ultraviolet light (UVA and UVB). Hydroalcoholic extracts of dried leaves are disclosed here as a rich source of anti-irritants. Likewise dried powders of cocoa bean plants, or commercial cocoa powder, and green tea leaves, contain both methyl xanthenes and polyphenols. Again, hydroalcoholic extracts of cocoa powder are disclosed here to be a rich source of anti-oxidants.
- the spice Cinnamon derived from the bark of Cinnamon trees has been reported to contain several polyphenolic compounds an active principle against diabetes (Ag Res Mag., April, 2004), a methyl hydroxychalcone polymer. Hydroalcoholic extracts of pure ground Cinnamon are disclosed here as potent anti-oxidants.
- this patent discloses methods for sourcing new anti-irritant botanicals and identification of anti-irritants among certain male flowering plant parts including corn plant tassels and several the male flowers of deciduous trees.
- all plant extracts which are rich in anti-oxidants botanicals that also test positive in the in vitro assay for detection of inhibitors of retinoid-stimulated autocrine growth of keratinocytes.
- FIG. 1 is a plot of antioxidant activity for standard antioxidants (50 ⁇ g/ml): Vitamin E( ⁇ ), Ascorbic acid, Ascorbyl palmitate, and Quercetin dihydrate (X).
- FIG. 2 is a plot of antioxidant activity some tested botanicals: CTS (X), AOB ( ⁇ ), GTL ( ⁇ ), GOL/RSC( ⁇ ).
- FIG. 2A is a table of the relative antioxidant activity of the botanicals ploted in FIG. 2 .
- FIG. 3 is a photograph showing the effect of Quercetin dihydrate on autocrine growth of HaCat keratinocytes, cultured under retinoid-stimulated autocrine growth conditions.
- FIG. 4 is a photgraph showing the effect of Allin on autocrine growth of HaCat keratinocytes.
- FIG. 5 is a photograph showing the effect of extracts from corn tassels (Tasselin) and tomato paste lycopenes, versus Quercetin on autocrine growth of Ha Cat keratinocytes.
- FIG. 6 is a bar chart showing elevated skin hydration following 24-hour occlusion of a 5% GTL extract when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). Effect of GTL on Skin Hydration: Vehicle (black bar); GTL (gray bar).
- FIG. 7 is a bar chart showing elevated skin hydration effect of AOB on Skin Hydration: Vehicle (while bar); AOB (black bar).
- FIG. 8 is a photograph of volar arm skin of human subject showing A) positive irritant control (0.5% BC only) versus B) 0.5% BC in combination with 5% Tasselin after 24 hours of occlusion.
- FIG. 9 is a table of Chromatographic data for corn tassel extract in methanol.
- FIG. 9A is a chromatograph showing the elution profile of corn tassel (Tasselin) extract versus authentic phenoxyacetic acid methyl ester.
- FIG. 10 is a UV-spectragraph of the corn tassel extract monitored by UV-scan of HPLC fractions.
- FIG. 11 is a table of antioxidant activity of solvent extracts of corn tassel pollen sacs.
- FIG. 1 shows a typical plot of antioxidant activity for several standard antioxidants as assayed by the DPPH* method.
- the molar activities of ascorbic acid, ascorbyl palmitate and vitamin E were calculated as 26 ⁇ M, 30 ⁇ M and 46 ⁇ M, respectively.
- Indole acetic acid, a weak free-radical scavenger had a molar activity of 190 ⁇ M
- a commercially purchased flavonoid, quercetin dihydrate it had an intermediate molar activity of 86 ⁇ M.
- FIG. 2 shows the results of assaying by the DPPH method the antioxidant activity of AOB, GTL, GOL, RSC and CTS.
- Table 1 FIG. 2A presents these results as “Relative EC 50 Value”, i.e., normalized to percent weight of total volume of extract.
- An immortalized line of human epidermal kertatinocytes can be cultured in a serum-free culture medium.
- Sterile Petri dishes 35 mm 2
- Sterile Petri dishes are seeded at 5,000 cells per cm 2 and placed in a humidified CO 2 incubator at 37° C. for 3-5 days or until the culture reaches about 30% confluent monolayer growth.
- the dishes are washed once with ice-cold serum-free media lacking EGF and insulin, and refed 2.5 ml of serum-free culture medium containing 5 ug/ml insulin and retinyl acetate (RA, 3 ⁇ 10 ⁇ 8 M).
- RA retinyl acetate
- Test ishes refed RA and insulin are split into three groups in duplicate. Group A is refed on the RA plus insulin medium.
- Group B is refed RA plus insulin medium and a TRK inhibitor (PD 15356), and Group C is refed medium containing RA plus insulin and from 0.1 to 5% of a hydroalcoholic botanical extract. All dishes are adjusted to have the same final concentration of alcohol (1%). All dishes are placed back in the incubator for 2 and 4 days. They are fixed and stained with 0.2% crystal violet. The stained dishes are photographed for comparison of results.
- FIG. 5 presents the results of a third study, where the effect of a semi-purified lycopene extract from tomato paste was compared with a hydroalcoholic extract of corn tassels (dubbed Tasselin).
- a hydroalcoholic solution of Quercetin dihydrate (10 ⁇ M) was included as a positive control. The results show that while lycopene had little or no effect, Tasselin was an effective inhibitor of RSA-RTK mediated autocrine regulation of growth of HaCat keratinocytes.
- hydroalcoholic extracts of ripe Autumn Olive berries, extracts prepared from green tea leaves and hydroalcoholic extracts from male flowers (catkins) of Oak and Linden trees were also effective in inhibiting RSA clonal growth of HaCat keratinocytes.
- All carrier system gels were prepared with 0.5% benzalkonium chloride, a mild irritant. To test for anti-irritancy, the irritant-containing carrier gels were also loaded with the test botanical extracts (experimentals). The control and test gels were deposited (100 microliters) on 10 mm square circular filter paper discs and placed in side of Finn chambers (20 mm square), which were then applied to the volar arm skin of volunteers. The chambers were affixed to skin with non-allergic adhesive tape and left in place for 24 hours. Upon termination of the treatments, the chambers were removed and the skin gently wiped clean with moistened cotton swabs.
- the exposed skin was first examined for signs of erythema (redness) and induration (swelling), and skin sites photographed.
- the exposed skin sites were probed for skin capacitance (skin moisture levels) using a Corneometer instrument (Courage & Khazaka, Koln, Germany).
- FIG. 6 presents results showing that a 5% GTL extract in vehicle gel elevated skin hydration following 24-hour occlusion when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). Similar results were obtained with 5% AOB extract ( FIG. 7 ).
- the increase in skin hydration may be due to an unexpected moisturizing effect of the botanicals as no visible signs of skin irritation were observed.
- FIG. 8 presents a photograph of volar arm skin exposed for 24 hours under occlusion to vehicle containing 0.5% Benzalkonium chloride (BC), the positive irritation control versus vehicle containing 0.5% BC in combination with 5% Tasselin (corn tassel extract).
- BC Benzalkonium chloride
- Tasselin corn tassel extract
- FIG. 9 presents the results showing the elution times for the four resolved peaks scanned by the UV-detector at 225 nm.
- FIG. 9A presents results showing the elution profile of corn tassel (Tasselin) versus authentic phenoxyacetic acid alkyl esters.
- FIG. 10 shows the UV-spectrum of the corn tassel extract. Note: the peak absorbance is at approximately 190 nm with a secondary peak at about 210 nm.
- Corn tassel spikelets were collected and stored at ⁇ 20 degrees centigrade. The material was placed in a clear polyethylene bag and the pollen and spikelet contents shaken loose and recovered separately. The collected pollen and pollen sacs were reddish brown in color and the average particle size was less than 0.5 cm in length. The material so obtained was stored again for varying periods of time at ⁇ 20 degrees centigrade. For the purposes of the following study, 0.2 grams of dried tassel pollen plus pollen sacs were thawed at room temperature, placed in a ceramic mortar and ground vigorously to a powder with a ceramic pestle. The powdered material was recovered and filtered through a metal cloth mesh (24 ⁇ 24 wires/inch). Greater than 90% of the powdered material passed through the mesh.
- the water extract had to be diluted 20 fold to obtain a linear reading.
- the interpolated concentration at which a 50% reduction in color occurred was calculated at a pwder concentration of 0.16%.
- the Methanol extract of the water-extracted tassel powder material had an equivalent antioxidant activity to the water extract, while the 70% ethanol-water extract had a lower activity, presumably because water and methanol extracts contained the bulk of the antioxidant activity.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Anti-irritant botanical extracts, and a method for screening, and then preparing, anti-irritant botanical extracts for use in topical formulations, providing a natural ingredient capable of preventing skin irritation when in combination with other active and inactive ingredients that have the potential to irritant skin
Description
- This application claims priority from Provisional Patent Application No. 60/588,460, filed Jul. 16, 2004.
- The technical field of the invention is in the area of manufacture of topical ingredients for skin and wound care. More especially in the processing and formulation of ingredients developed from natural products, which possess anti-irritant and/or free radical scavenging antioxidant properties.
- Among the agents recently proposed for minimizing skin irritation due to skin irritants are fibers (Creton, I., 2002. U.S. Patent Appl., 20020182238A1), and an immune suppressant such as a composition that blocks CD1d activation (Wilson, S. B., 2002. U.S. Patent Appl., 20020165170A1), discloses a method that blocks antigen presentation by skin located immune cells. Lacharriere et al., have proposed the use of a histamine antagonist and or a TNF-alpha antagonist (Lacharriere, O. De; et al., 2001 in U.S. Appl., No.: 20010022978A1).
- Historically, plants have been an important source of both new pharmaceuticals and new cosmetic ingredients. Even today plants have yield more new medicinal compounds and cosmetic ingredients than the chemical synthesis approaches exemplified by the recent reliance on combinatorial chemistry methods (C&EN, Oct. 13, 2003).
- The search for novel natural products from plants has led to a worldwide search for exotic plants in tropical rainforests of the Amazon and to the ocean depths. This has produced an array of new plant oils that fill the catalogs of commercial cosmetic ingredient suppliers, and to the harvesting of bacteria that inhabit temperature extremes for the purposes of isolating their heat stable enzymes. Yet, it must be noted, that the screening of higher plants for their useful drugs and cosmetic active ingredients has barely scratched the surface of the more than 250,000 species of flowering plants (Angiosperms), and very few of the 50,000 species of monocots (grasses and ornamentals) relatives to the 200,000 species of dicot herbs, shrubs, trees, and ornamentals). Below the flowering plant, aside from a few hallucinogenic mushrooms, and algal plants and bacteria that produce abundance polysaccharide gums, the realm of other plant phyla has been totally neglected. Aside from the lethal phytotoxins from red tides caused by unicellular Dinoflagellates, none of the highly diverse unicellular plants algae have been screened for useful drugs and cosmetics. Thus, it fair to conclude that a systematic and rationale approach to this task has yet to be formulated.
- The inventor has taken a different approach to the search for novel botanicals, i.e., plants with medicinal or cosmetic value. This approach narrows the search to plants that grow in the wild, and are cultivated primarily as a foodstuff but for which there is no present commercial medicinal or cosmetic uses. This has led to the discovery of many novel sources of plant derived anti-oxidants some of which are also anti-irritants
- A truly effective anti-irritant strategy seeks to modulate checkpoints in the irritant signal cascade. Earlier, Wille & Kydonieus (2000) reviewed the scientific and patent literature on anti-irritants. The aim of which was to find new agents useful in prevention and treatment of contact irritant due to topical cosmetic, dermatological and transdermal drugs. In a series of patents (Wille, U.S. Pat. No. 6,670,395, 2003; Wille, U.S. Pat. No. 5,716,987, 1998; Wille and Kydonieus, U.S. Pat. No. 5,843,979, 1998; Wille, Kydonieus and Castellan, U.S. Pat. No. 5,618,557, 1997; Wille and Kydonieus, U.S. Pat. No. 5,686,100, 1997; Wille and Kydonieus, U.S. Pat. No. 5,912,010, 1999; Wille, Kydonieus and Castellana, WO Pat. No. 9,718,782, 1997; Wille and Kydonieus, European Pat. No. 5,612,525, 1994; and in reports (Kalish R, Wood J, Wille J, and Kydonieus A, 1995; Wille, J J., Kydonieus, A., and Kalish, R S., 1998; Wille, J J., Kydonieus, A., and Kalish, R S., 1999a; Wille, J J, Kydonieus, A F., and Murphy, G F., 1999b; Wille, J J., Kydonieus, A F, and Kalish, R S., 2000; Wille and Kydonius, 2001; Wille, Kydonieus and Castellana, WO Pat. No. 9,718,782, 1997), it was shown that ion channel modulators and mast cell degranulating agents were effect anti-irritants and counter-sensitizers. Ethacrynic acid (Edacrinn, Merck) was effective in preventing contact sensitization due to the delivery to mouse skin of four sensitizing drugs: Clonidine, Chlorpheniramine, Albuterol, and Nadolol. Ethacrynic acid, a potassium ion channel blocker, was also effective in preventing skin irritation due to the topical application to mouse of 2,4-dinitro-chlorobenzene, arachidonic acid, phorbol myristic acid, trans-retinoic acid, and lactic acid. The calcium ion channel blockers Nifedipine and Verapamil were effective in minimize contact sensitization in mouse skin due to topical application of the sensitizing and transdermally delivered drug, Nadolol. Phenoxyacetic acid and its alkyl derivatives, non-drug analogs of the diuretic, ethacrynic acid, were shown to prevent contact sensitization due to application to mouse skin of the sensitizing hair dye, para-phenylenediamine and to block skin irritation due a panel of known skin irritants, including anionic surfactants such as sodium lauryl sulfate. Finally, agents which induce mast cell degranulation such as cis-urocanic acid and capsaicin were reported to prevent contact sensitization in a mouse skin model.
- Natural products and plant extracts have been the focus of recent interest as emollients and anti-irritants. Castro J (1995) in U.S. Pat. No. 5,393,526 discloses Rosmarinic acid (5%), derived from Sage plant, was able to reduce by more than three-fold the irritating action of alpha-hydroxy acids (lactic and glycolic acids). Pretreatment, one-half hour prior to application of cosmetic formulation containing known skin irritants, by para-aminobenzoic acid and balsam of Peru with extracts the Cola nitida plant, have been disclosed in European Pat. No. Application 0,354,554A2 to prevent skin irritation. Oil from Yerba plants have also been claimed in World Pat. No. Application WO 9,114,441 to eliminate irritation and sensitization that accompanies topical, tranmucosal and transdermal delivery of dihydroergotamine mesylate, acetominophen, oxymetazoline, diphenhydramine, nystatin, clindamycin, and para-aminobenzoic acid. Oils of chamomile, containing chamazulene isolated from yarrow, chamomile and wormwood, were disclosed in U.S. Pat. No. 4,908,213 to be good antipuretics when co-administered in transdermal Nicotine patches.
- Depletion of antioxidants is known to cause oxidative damage to human skin (Podda et al, 1998). As discussed above, flavonoids are known to be potent anti-oxidants. Topical replacement of skin anti-oxidants may help to alleviate damage due to ultraviolet radiation and ozone exposure. Flavonoids require stabilization against oxidation by addition of co-reductants such as Vitamin E (α-tocopherol) or Vitamin C (Ascorbic Acid). No mechanism exists to reduce oxidized Vitamin E since there is no Ascorbic acid in the upper layers of the epidermis (stratum corneum). Lazendorfer et al., (2002) in U.S. Pat. No. 6,423,747 discloses cosmetic and dermatological preparations with favonoids having anti-oxidant properties. Illustrative examples mention standard water-in-oil and oil-in-water formations without providing any evidence of their efficacy in these formulations.
- Of particular importance to the category of polyphenols and flavonoids is the demonstration (Wille, 2003) that the mechanism of action for many plant-derived anti-irritants is their inhibition of protein tyrosine kinases associated with growth factor receptor stimulated autocrine control of cell proliferation that is the hallmark of many useful skin products that cause skin irritation, i.e., retinoic acid. The use of flavonoids as anti-irritants are among the plant-derived anti-irritants that are readily formulated in the novel hydrophobic delivery system claimed in this patent. They include many plants and herbs are rich in flavonoids as well as flavonoids present in Spanish Honeybee pollen. For example, rutin, quercetin, myricetin, and trans-cinnamic acid; all were present at >350 mg/100 g. Recently, it was reported (Bonina et al, 2002), that Kaempferol is the major flavonoid derived from lyophilized extracts of the flowering buds of capers (Capparis spinosa L). This material was shown to have both anti-oxidant and photo-protective effects in human skin.
- Antioxidants and free radical scavengers have been employed in many patented formulations for eliminating or minimizing irritation and contact sensitization reactions. Inhivbitors of the metabolites of the arachidonic acid cascade known to be involved in the irritant mechanism of skin have been claimed in European Pat. No. EP 0,314,528A1. Among the designated anti-irritants claimed were Vitamin E, BHT, para-tertiary butyl catechol, hydroquinone, benzoquinone, N,N-diethylhydroxyamine, and nordihydroguaiareic acid.
- Vitamin C (ascorbic acid), a water soluble antioxidant, was disclosed in U.S. Pat. No. 5,516,793 to be effective in decreasing skin irritation caused by topical application of such ingredients as: a-hydroxy acids, benzoyl peroxide, retinal, retinoic acid, quaternary ammonium lactates, and salicylic acid. Vitamin E (a-tocopherol) is disclosed in U.S. Pat. No. 5,545,407 to reduce skin irritation caused by actives in dermatological preparations containing benzoyl peroxide., and in U.S. Pat. No. 5,252,604 it was disclosed that topical α-tocopherol reduced skin irritation due to repeated doses of retinoic acid. Another antioxidant panthenol and its derivatives pantothenic acid, pantethine and pantetheine have been claimed as anti-irritants for formulations containing up to 20% benzoyl peroxide.
- The role of antioxidants in protecting the skin from harmful solar exposure, and photoaging is well known. In their book, “Oxidants and Antioxidant in Cutaneous Biology, Thiele and Elsner (2001) have assembled a comprehensive review of free radical chemistry in the skin and the antioxidant network of defense in the stratum corneum. Among the antioxidants discussed for protection of skin are Vitamins E and Vitamin C, green tea polyphenols, resveratol, curcumin, silymarin, ginger, and diallyl sulfide, all of which afford some protection against the development of skin cancer. In addition, the role of carotenoids (lycopenes, luein and α, and β-carotene) as dietary supplements in chemoprevention of cancer were reviewed. The protective effect of topical anti-oxidants against solar radiation result from e.g.: Vitamin E and Vitamin C. Other reported antioxidants that efficiently reduce photodamage include the thiol, N-acetylcysteine and α-lipoic acid, which may prevent oxidative stress in skin. In addition, plant-derived flavonoids (apigerneic genistein, catechin, epicatechin, a-glycosylrutin and silymarin) are polyphenols with good antioxidant activity.
- Vitamins C and E are routinely used as antioxidants to either stabilize cosmetic ingredients or more recently for their anti-aging free-radical scavenging properties. The most widely used botanical with accepted anti-irritant activity are is Aloe gel; and Witch Hazel (Hammelis Water) containing polymeric proanthocyanidins is by far the best documented case of a botanical anti-irritant. Other botanically-derived actives with potential anti-irritant activity are the catechins and polyphenols, e.g., green tea leaves, and grape seed oil extracts. Additional antioxidants derived from botanicals are Bisabolol, Epigallocatechine, Epigallocatechinegallate Rutin, Quercetin, Hesperidin, Diomine, Mangiferin, Mangostin, Cyanidin chloride, Astaxanthin, Xanthophylls, Lycopene, Reversatrol, Tetrahydrodiferuloylmethane, Rosmarinic acid, Hypericin, Ellagic acid, Chlorogenic acid, Oleoeuropein, Thiotic acid, Glutathione, and Andrographolide (Gupta, 2001). Few of these have been rigorously shown to have anti-irritant activity. Nevertheless, the prospects for broadening the base of plant derived anti-irritants is tremendous because only a small fraction of the over 250,000 known Angiosperm species has been explored.
- Here we claim the anti-irritant and antioxidant activity of several new plant-derived anti-irritants. They include a botanical anti-irritant isolated from corn plant tassels, dried lavender flowers, dried flowers of Hops plants, catkins of the Oak tree (Quercus sp.), catkins of the Linen tree (Tialia sp.), an extract from green tea leaves, green onion leaves; and extract from ripened Autumn Olive berries. These extracts have been incorporated into a novel carrier system (Wille, Novel Delivery Systems, 2004), especially designed to improve their cutaneous delivery.
-
- Creton, I. U.S. Pat. No. Application No.: 20020182238A1. Fibers as anti-irritant agents.
- Korneyev, A. Y. U.S. Pat. No. 6,576,269 (Jun. 10, 2003). Treating open skin lesions using extract of sea buckthorn
- Perricone. U.S. Pat. No. 6,437,004 (Aug. 20, 2002). Treatment of skin damage using olive oil polyphenols.
- Wilson, S. B. U.S. Pat. No. Application No.: 20020165170A1. Method of attenuating reactions to skin irritants.
Other Publications: - J J Wille. Provisional Pat. No. Application No.: Novel Topical Delivery System for Plant Derived Anti-irritants (Jul. 4, 2003).
- J J. Wille. U.S.P.T.O Disclosure.—“Anti-Irritant Compounds Derived from Plant Extracts (Jun. 18, 2002).
- J J Wille. Novel Plant-Derived Anti-Irritants. Abstract in: J. Cosmet. Sci., 54: 106-107, 2003
- J J Wille. Novel Topical Delivery System for Plant derived Hydrophobic Anti-Irritant Actives. Abstract presented at National Annual ACS Meeting NY, N.Y. (Sep. 17, 2003).
- J J Wille. Plant-derived anti-irritants. In Closing with John Wille. Cosmetics & Toiletries Vol. 118(8): 128, 2003.
- J J Wille. Thixogel: Novel Topical Delivery System for Hydrophobic Plant Actives. In: Personal Care Delivery Systems and Formulations Noyes Publication (in press).
- J J Wille. Cutaneous delivery of Antioxidant Botanicals. 23rd Annual Congress of IFSCC Abstract (October 2004, in press).
- There is disclosed here a method for screening, and then preparing anti-irritant botanical extracts for use in topical formulations in need thereof of a natural ingredient capable of preventing skin irritation when in combination with other active and inactive ingredients that have the potential to irritant skin. In addition, the natural botanical anti-irritants disclosed herein can be topically applied to skin in a formulation without an irritant for the purpose of preventing skin damage due to solar exposure or to oxidant type pollutants in the environment.
- Applicant has developed a novel means of screening for potential plant-derived anti-irritants following the strategy and testing assay was developed (USPTO Disclosure Document No. 514152, June 2002). Human epidermal keratinocytes cultured in a serum free culture medium require protein, two growth factors: insulin and epidermal growth factor (EGF) (Wille et al, 1984), by substituting retinyl acetate for EGF one can sustain continued proliferation under autocrine production of HB-EGF (HB-heparin binding), due to retinoid-inducible HB-EGF growth factor receptor (Wille, J. Invest. Dermatol., SID Abstract, 2002). Applicant has shown by use of a specific phosophotyrosine kinase (TRK) inhibitor, that retinoid inducible keratinocyte cell proliferation is dependent on TRK phosphorylation of the insulin growth factor receptor. In light of these discoveries, the inventor postulated that anti-irritants prevent epidermal hyperplasia by blocking retinoid inducible TRK activation of growth factor receptors. Therefore, the search for novel plant-derived anti-irritants involves screening plant extracts that inhibit retinoid-inducible autocrine regulation of human epidermal keratinocyte proliferation in a specially designed clonal growth assay. This assay has uncovered many potential plant-derived anti-irritants.
- The methods developed for preparing novel anti-irritant botanicals involves two steps, the sourcing and harvesting of plant materials and a novel processing methods.
- The aroma of herbs has been a source of botanicals with health, beauty and medical value since prehistoric times. Minoan archeological (2,500 BC) sites have revealed the use of botanical herbs that are still in use in the present day culinary arts of Crete and Greece (Greek book). As many as 70 different species were recorded by Theophrastus from Crete in Roman times including Dittany, a relative of the herb, Oregano.
- The aroma of plants may be used as a to guide to possible sources of new botanicals. In particular, certain phenoxy acids and benzoic acid derivatives have a peculiarly pungent smell. The inventor has previously disclosed that phenoxyacetic acid esters are in fact anti-irritants in U.S. Pat. No. 6,670,395(2003). Thus, the Inventor has relied primarily on his sense of smell to detect and source many novel anti-irritant plants. There include aromatic tassels of corn plants, and the male flowering structures of Oak (Quercus genus), Linden (Tilia genus) and Mimosa trees. All of which produce hydroalcoholic extracts enriched in anti-oxidants.
- Another source of botanicals with potential anti-oxidant and anti-irritant properties are edible plant fruiting bodies; in particular, the ripe red edible berries of Autumn Olive (Eleagnus umbellate) trees, and the orange berries of Sea Buckthorn (Hippophae rhanmoides), a closely related member of the Eleagnacae family.
- Hops (Humulus lupulus) grown in Europe since the 14th Century as a bitter substance for brewing of beer was later discovered to contain lupulin, bitter resinous substances (lupulone, humulone) and essential oils in the strobiles from female plants. These lupulins are reputed to have drug like activities for relieving anxiety and inducing sleep. Modern-day cosmetics use this plant in a different form for its beta-hydroxy acids. It is our finding that this scented herb is highly enriched in anti-oxidants.
- Green tea leaves are rich in methyl xanthenes (caffeine, theophylline) and antioxidant polyphenols including catchins, and epigallocatechins. They have been the subject of much recent work on topical and dietary use to prevent cancer, and photodamage by exposure to ultraviolet light (UVA and UVB). Hydroalcoholic extracts of dried leaves are disclosed here as a rich source of anti-irritants. Likewise dried powders of cocoa bean plants, or commercial cocoa powder, and green tea leaves, contain both methyl xanthenes and polyphenols. Again, hydroalcoholic extracts of cocoa powder are disclosed here to be a rich source of anti-oxidants. The spice Cinnamon derived from the bark of Cinnamon trees has been reported to contain several polyphenolic compounds an active principle against diabetes (Ag Res Mag., April, 2004), a methyl hydroxychalcone polymer. Hydroalcoholic extracts of pure ground Cinnamon are disclosed here as potent anti-oxidants.
- In summary, this patent discloses methods for sourcing new anti-irritant botanicals and identification of anti-irritants among certain male flowering plant parts including corn plant tassels and several the male flowers of deciduous trees. In general, all plant extracts which are rich in anti-oxidants botanicals that also test positive in the in vitro assay for detection of inhibitors of retinoid-stimulated autocrine growth of keratinocytes. These methods have proved to be reliable indicators of anti-irritant activity of plant extracts.
-
FIG. 1 is a plot of antioxidant activity for standard antioxidants (50 μg/ml): Vitamin E(▪), Ascorbic acid, Ascorbyl palmitate, and Quercetin dihydrate (X). -
FIG. 2 is a plot of antioxidant activity some tested botanicals: CTS (X), AOB (⋄), GTL (▪), GOL/RSC(●). -
FIG. 2A is a table of the relative antioxidant activity of the botanicals ploted inFIG. 2 . -
FIG. 3 is a photograph showing the effect of Quercetin dihydrate on autocrine growth of HaCat keratinocytes, cultured under retinoid-stimulated autocrine growth conditions. -
FIG. 4 is a photgraph showing the effect of Allin on autocrine growth of HaCat keratinocytes. -
FIG. 5 is a photograph showing the effect of extracts from corn tassels (Tasselin) and tomato paste lycopenes, versus Quercetin on autocrine growth of Ha Cat keratinocytes. -
FIG. 6 is a bar chart showing elevated skin hydration following 24-hour occlusion of a 5% GTL extract when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). Effect of GTL on Skin Hydration: Vehicle (black bar); GTL (gray bar). -
FIG. 7 is a bar chart showing elevated skin hydration effect of AOB on Skin Hydration: Vehicle (while bar); AOB (black bar). -
FIG. 8 is a photograph of volar arm skin of human subject showing A) positive irritant control (0.5% BC only) versus B) 0.5% BC in combination with 5% Tasselin after 24 hours of occlusion. -
FIG. 9 is a table of Chromatographic data for corn tassel extract in methanol. -
FIG. 9A is a chromatograph showing the elution profile of corn tassel (Tasselin) extract versus authentic phenoxyacetic acid methyl ester. -
FIG. 10 is a UV-spectragraph of the corn tassel extract monitored by UV-scan of HPLC fractions. -
FIG. 11 is a table of antioxidant activity of solvent extracts of corn tassel pollen sacs. - Botanical Extraction:
- An equal volume of ice-cold 95% alcohol was added to 100 grams of either dried or wet weight (w/v) of minced plant material and the mixture blended at 23° C. for 2 minutes. The homogenate was clarified by low speed centrifugation at 5° C. and sterile filtered through (0.45 micron filter). All hydroalcoholic extracts so prepared were stored at 0-4° C. and protected from light until further use. Extract concentration was calculated using the percent weight of botanical material to the total volume of botanical weight plus extraction volume. This was 36% (w/v) for Autumn Olive berries (AOB), 5% f (w/v) for Corn Tassel Spikelets (CTS), 11% (w/v) for dried Green Tea Leaves (GTL), 37% (w/v) for Green Onion leaves (GOL), and 36% (w/v) for Red Swiss Chard (RSC, 36% wet weight).
- Anti-Oxidant Assay:
- Aliquots of botanical hydroalcoholic extracts were assayed for their antioxidant activity by the diphenylpicryl hydrazine (DPPH*) reagent method as described previously (Bonina et al, 2003). In order to standardize the activity of extracts, we defined for each extract an EC50 value as the concentration of extract that lowers the zero time optical absorbance of DPPH at 515 nm by 50 percent measured after 30 minutes of incubation at 25° C. Antioxidant activity of extracts was calculated by multiplying its EC50 value by a weighting factor representing the percent weight of the starting material in the extract.
- Antioxidant Activity of Botanicals.
-
FIG. 1 shows a typical plot of antioxidant activity for several standard antioxidants as assayed by the DPPH* method. The molar activities of ascorbic acid, ascorbyl palmitate and vitamin E were calculated as 26 μM, 30 μM and 46 μM, respectively. Indole acetic acid, a weak free-radical scavenger, had a molar activity of 190 μM, Finally, a commercially purchased flavonoid, quercetin dihydrate; it had an intermediate molar activity of 86 μM. -
FIG. 2 shows the results of assaying by the DPPH method the antioxidant activity of AOB, GTL, GOL, RSC and CTS. Table 1 (FIG. 2A ) presents these results as “Relative EC50 Value”, i.e., normalized to percent weight of total volume of extract. - We have assayed many other botanical hydroalcoholic extracts for their antioxidant activity including: Aloe leaf, Cocoa powder (Hershey brand), Cinnamon spice, Cranberry (27% juice), grapefruit seed oil (Citricidal®), Hops flowers (Humulus lupulus), dried Lavender flowers, ripe red seedless grapes, rhubarb stems, lycopenes purified from tomato paste, carotenes purified carrots, oleic acid, catkins from Linden tree (Tilia americanus sp), and catkins from oak tree (Quercus sps.), tea tree oil, various commercial food grade vegetable oils, and tomato paste. The majority of these extracts had antioxidant activity less than green tea leaves.
- Since retinoids irritate skin leading to epidermal hyperplasia, it is the inventors idea that plant extracts that act as inhibitors of retinoid -stimulated autocrine growth are themselves anti-irritants. This hypothesis was tested using an in vitro keratinocyte culture model.
- An immortalized line of human epidermal kertatinocytes, HaCat keratinocytes, can be cultured in a serum-free culture medium. Sterile Petri dishes (35 mm2) are seeded at 5,000 cells per cm2 and placed in a humidified CO2 incubator at 37° C. for 3-5 days or until the culture reaches about 30% confluent monolayer growth. The dishes are washed once with ice-cold serum-free media lacking EGF and insulin, and refed 2.5 ml of serum-free culture medium containing 5 ug/ml insulin and retinyl acetate (RA, 3×10−8 M).—Duplicate control dishes are fixed and stained with 0.2% crystal violet to record the—amount of clonal growth prior to refeeding with fresh RA-containing medium. Test—dishes refed RA and insulin are split into three groups in duplicate. Group A is refed on the RA plus insulin medium. Group B is refed RA plus insulin medium and a TRK inhibitor (PD 15356), and Group C is refed medium containing RA plus insulin and from 0.1 to 5% of a hydroalcoholic botanical extract. All dishes are adjusted to have the same final concentration of alcohol (1%). All dishes are placed back in the incubator for 2 and 4 days. They are fixed and stained with 0.2% crystal violet. The stained dishes are photographed for comparison of results.
- As a proof of principle the effect of Quercetin dihydrate (10 μM) a known inhibitor of growth factor receptor TRK on HaCat clonal growth was compared with growth of HaCat cells grown without Quercetin dihydrate, and both cultured under retinoid-stimulated autocrine growth conditions. As predicted,
FIG. 3 shows that 48 hours after treatment with Quercetin dihydrate clonal growth was completely inhibited relative to the untreated control. - In a second study, the effect of a hydroalcoholic extract of green onion leaves (dubbed Allin) on RSA clonal growth was examined. Green onion leaves have been reported to have 1498 mg/k of the aglycone flavonol Quercetin (Miean et al, 2001).
FIG. 4 shows that Allin was effectively inhibited autocrine growth of HaCat keratinocytes. -
FIG. 5 presents the results of a third study, where the effect of a semi-purified lycopene extract from tomato paste was compared with a hydroalcoholic extract of corn tassels (dubbed Tasselin). A hydroalcoholic solution of Quercetin dihydrate (10 μM) was included as a positive control. The results show that while lycopene had little or no effect, Tasselin was an effective inhibitor of RSA-RTK mediated autocrine regulation of growth of HaCat keratinocytes. - Further studies showed that hydroalcoholic extracts of ripe Autumn Olive berries, extracts prepared from green tea leaves and hydroalcoholic extracts from male flowers (catkins) of Oak and Linden trees were also effective in inhibiting RSA clonal growth of HaCat keratinocytes.
- Anti-Irritant Assays.
- All carrier system gels were prepared with 0.5% benzalkonium chloride, a mild irritant. To test for anti-irritancy, the irritant-containing carrier gels were also loaded with the test botanical extracts (experimentals). The control and test gels were deposited (100 microliters) on 10 mm square circular filter paper discs and placed in side of Finn chambers (20 mm square), which were then applied to the volar arm skin of volunteers. The chambers were affixed to skin with non-allergic adhesive tape and left in place for 24 hours. Upon termination of the treatments, the chambers were removed and the skin gently wiped clean with moistened cotton swabs. The exposed skin was first examined for signs of erythema (redness) and induration (swelling), and skin sites photographed. The exposed skin sites were probed for skin capacitance (skin moisture levels) using a Corneometer instrument (Courage & Khazaka, Koln, Germany).
- Anti-Irritant Activity of Botanicals:
- Occlusive patch testing was conducted on extracts prepared by starch gel encapsulation in an oil-in water emulsion system previously described (Wille, 2003).
FIG. 6 presents results showing that a 5% GTL extract in vehicle gel elevated skin hydration following 24-hour occlusion when co-administered in the carrier gel with a irritating concentration of Benzalkonium Chloride (0.5%). Similar results were obtained with 5% AOB extract (FIG. 7 ). The increase in skin hydration may be due to an unexpected moisturizing effect of the botanicals as no visible signs of skin irritation were observed. -
FIG. 8 presents a photograph of volar arm skin exposed for 24 hours under occlusion to vehicle containing 0.5% Benzalkonium chloride (BC), the positive irritation control versus vehicle containing 0.5% BC in combination with 5% Tasselin (corn tassel extract). The photograph shows that Tasselin in the presence of BC suppressed BC-induced redness and skin eruptions seen in the irritant control, i.e., Tasselin is an anti-irritant. - In summary, the results of our studies have demonstrated that the cold-processing and hydroalcoholic extraction methods developed to extract botanicals from dried, powdered or wet weight of plant materials is satisfactory in preserving the anti-oxidant as well as the anti-irritant activity of select botanicals. Among the extracts analyzed, Autumn Olive berries have good antioxidant activities similar to that found for green tea leaf extracts. Although, we have not yet been performed detailed chemical analyses, preliminary work suggests that Autumn Olive berries are rich in polyphenols, while Corn tassel extracts have gallocatechins and polyphenols. The anti-irritant properties of Autumn Olive berry and corn tassel extracts may be due to their antioxidant activity as a oxidative loss of anti-oxidant activity coincides with a loss in anti-irritant activity.
- A methanol extract of corn tassels was dried by rotary evaporation and taken up in methanol. The concentrated extract was diluted in chromatographic solvent and used to perform HPLC (high pressure liquid chromatography) studies. Table 2 (
FIG. 9 ) presents the results showing the elution times for the four resolved peaks scanned by the UV-detector at 225 nm.FIG. 9A presents results showing the elution profile of corn tassel (Tasselin) versus authentic phenoxyacetic acid alkyl esters.FIG. 10 shows the UV-spectrum of the corn tassel extract. Note: the peak absorbance is at approximately 190 nm with a secondary peak at about 210 nm. - Preparation of Anti-oxidant Extracts from Powdered Corn Tassel Spiklets
- Corn tassel spikelets were collected and stored at −20 degrees centigrade. The material was placed in a clear polyethylene bag and the pollen and spikelet contents shaken loose and recovered separately. The collected pollen and pollen sacs were reddish brown in color and the average particle size was less than 0.5 cm in length. The material so obtained was stored again for varying periods of time at −20 degrees centigrade. For the purposes of the following study, 0.2 grams of dried tassel pollen plus pollen sacs were thawed at room temperature, placed in a ceramic mortar and ground vigorously to a powder with a ceramic pestle. The powdered material was recovered and filtered through a metal cloth mesh (24×24 wires/inch). Greater than 90% of the powdered material passed through the mesh. It was added to a sterile 15 ml conical centrifuge tube and the powdered material was sequentially extracted with 5.0 ml each of a) distilled water, b) 100% methanol and c) 70% ethanol at 25 degrees centigrade. Each final extract was therefore prepared as a 4% (w/v) sample, and were clarified by low speed centrifugation at 5 degrees centigrade for 10 minutes at 3,000 rpm. The resulting solutions were examined for free-radical scavenging activity by the standard diphenyl picryl hydrazine (DPPH*) assay according to the method of Bonina et al (2003). Table (X) presents the results as Percent Decoloration of the DPPH solution after 30 minutes of reaction at room temperature as measured in a Spectrophotometer at 595 nm. The absorbance data are recorded as Optical Density readings.
- Note: The water extract had to be diluted 20 fold to obtain a linear reading. The interpolated concentration at which a 50% reduction in color occurred was calculated at a pwder concentration of 0.16%. The Methanol extract of the water-extracted tassel powder material had an equivalent antioxidant activity to the water extract, while the 70% ethanol-water extract had a lower activity, presumably because water and methanol extracts contained the bulk of the antioxidant activity.
- The presence of gallo-tannins in the powder extracts was confirmed by development of a positive black color upon drop-wise addition of 10% FeCl3 to a 5% dilution of the 4% (w/v) extracts.
- There has thus been shown and described a novel anti-irritant botanical extracts and methods for making the same, of which fulfill all the objects and advantages sought therefore. Many changes, modifications, variations and other uses and applications of the subject invention will, however, become apparent to those skilled in the art after considering this specification and the accompanying drawings which disclose the preferred embodiments thereof. All such changes, modifications, variations and other uses and applications which do not depart from the spirit and scope of the invention are deemed to be covered by the invention, which is to be limited only by the claims which follow.
Claims (20)
1. Anti-irritants hydro-alcoholic extracts from minced plant material prepared by the method of:
1) blending equal volumes of alcohol at about 4degrees C., and minced plant material, minced plant material selected from the group consisting of Aloe leaf, Autumn Olive berries (Eleagnus umbellata) berries, Green Tea leaves (Camellia sinensis) leaves, Green Onion leaves (Allum sp), Red Swiss Chard leaves; dried oregano leaves, curly dock seeds (Rumex), grapes, carrots, rhubarb, dried Lavender flowers (Lavendula), tomato paste, Hops (Humulus lupulus), and commercially prepared powders of cocoa nuts, and cinnamon bark, cinnamon bark, cocoa powder, aloe leaves, cranberry, grapefruit seed, hops flowers, dried lavender flowers, ripe red seedless grapes, rhubarb stems, tomato paste, carrots, catkins from linden tree, catkins from oak tree, and
2) clarifying the homogenate produced thereby, using low speed centrifugation at 5 degrees C. followed by sterile filtration of the extract.
2. Anti-irritant extracts as prepared as in claim 1 , wherein the plant material is male flowering parts of angiosperm plants.
3. Anti-irritant extracts as prepared as in claim 2 , wherein the anti-irritant is an antioxidant.
4. Corn Tassel extract prepared by the method of:
1) blending equal volumes of alcohol at about 4 degrees C., and minced corn tassel spikelets, to form a 50% alcohol extract, and
2) combining the 50% hydroalcoholic extract with a second time extract obtained by re-extracting the once extracted tassel material with an equal volume of 95% alcohol at 23 degrees centigrade, and
3) drying the combined hydroalcoholic extracts, followed by several water rinses of the air dried powder, followed by dissolving the powder in 95% alcohol, and.
4) clarifying the solution produced thereby, using low speed centrifugation at 5 degrees C., followed by sterile filtration of the extract.
5. Anti-irritant compositions comprising extracts of claim 3 , wherein the anti-oxidant activity is derived from grapefruit seeds, and further comprising polyunsaturated oils selected from the group consisting of soy bean oil and cottonwood seed oil.
6. Anti-irritant compositions comprising the extract of claim 1 , comprising purified lycopene fraction of Autumn olive berry seeds (Eleagnus umbellate)
7. Anti-irritant compositions comprising anti-oxidant plant growth hormone including indole acetic acid and related congeners.
8. Anti-irritant compositions comprising the extract of claim 1 , further comprising urocanic acid.
9. Anti-irritant compositions comprising the extract of claim 1 , further comprising anti-oxidants present in the stratum corneum of human skin.
10. Skin care formulations comprising the anti-irritant extracts of claim 1 .
11. Skin care formulations comprising the anti-irritant extracts of claim 2 .
12. Skin care formulations comprising the anti-irritant extracts of claim 3 .
13. Skin care formulations comprising the anti-irritant extracts of claim 4 .
14. The use of anti-irritant extracts of claim 1 to prevent skin damage associated with environmental oxidants.
15. The use of anti-irritant extracts of claim 2 to prevent skin damage associated with environmental oxidants.
16. The use of anti-irritant extracts of claim 3 to prevent skin damage associated with environmental oxidants.
17. The use of anti-irritant extracts of claim 4 to prevent skin damage associated with environmental oxidants.
18. A method for identifying anti-irritant botanicals by detection of their anti-oxidant activity combined with their inhibitory effect on retinoid-stimulated autocrine (RSA) growth of keratinocytes in a serum-free in vitro clonal growth assay.
19. A method for preparing an anti-irritant and anti-oxidant extract from the male flowering parts of angiosperm plants, prepared by the method of:
1) drying the plant material, and grinding it to a powder; and
2) sequentially extracting with first distilled water, then methanol, and finally with absolute ethanol.
20. The method of claim 19 , wherein the final concentration of the extracts is from 1 to 5% (w/v) of the initial powdered plant material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/183,495 US7399493B2 (en) | 2004-07-16 | 2005-07-18 | Anti-irritant botanicals |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58846004P | 2004-07-16 | 2004-07-16 | |
US11/183,495 US7399493B2 (en) | 2004-07-16 | 2005-07-18 | Anti-irritant botanicals |
Publications (2)
Publication Number | Publication Date |
---|---|
US20060062861A1 true US20060062861A1 (en) | 2006-03-23 |
US7399493B2 US7399493B2 (en) | 2008-07-15 |
Family
ID=36074311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/183,495 Expired - Fee Related US7399493B2 (en) | 2004-07-16 | 2005-07-18 | Anti-irritant botanicals |
Country Status (1)
Country | Link |
---|---|
US (1) | US7399493B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120164185A1 (en) * | 2010-12-28 | 2012-06-28 | Barry Markman | Oral nutrient or medicant carrier having increased surface area and absorption rate |
US20140316175A1 (en) * | 2011-12-31 | 2014-10-23 | Chenguang Biotech Group Co. Ltd. | Process for Extracting Lycopene |
US11744793B2 (en) * | 2016-04-08 | 2023-09-05 | Givaudan Italia S.p.A. | Cosmetic compositions for protection against air pollutants |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100158842A1 (en) * | 2008-10-09 | 2010-06-24 | Spectrum Dynamics Llc | Natural skin whitener: 4-hydroxy-oxindole-3-acetic acid |
CN107549713A (en) * | 2017-09-27 | 2018-01-09 | 甘肃银河食品集团有限责任公司 | A kind of processing method of onion freeze-dried powder |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
US4950481A (en) * | 1984-09-21 | 1990-08-21 | Innofinance Altalanos Innovacios Penzintezet | Skin regenerating and hydrating cosmetic compositions and process for the preparation of the active ingredient |
US5252604A (en) * | 1992-07-10 | 1993-10-12 | Hoffmann-La Roche Inc. | Compositions of retinoic acids and tocopherol for prevention of dermatitis |
US5393526A (en) * | 1994-02-07 | 1995-02-28 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic compositions |
US5516793A (en) * | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
US5545407A (en) * | 1994-10-20 | 1996-08-13 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith using benzoyl peroxide and tocopherol esters |
US5618577A (en) * | 1993-07-02 | 1997-04-08 | Congoleum Corporation | Release coating |
US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US5716987A (en) * | 1996-06-21 | 1998-02-10 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US5843979A (en) * | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
US20010022978A1 (en) * | 1994-12-28 | 2001-09-20 | Lacharriere Olivier De | Cosmetic, pharmaceutical or dermatological composition comprising a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist |
US6423747B1 (en) * | 1994-12-13 | 2002-07-23 | Beiersdorf Ag | Cosmetic and dermatological preparations with flavonoids |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01265021A (en) | 1987-10-29 | 1989-10-23 | Hercon Lab Corp | Article for discharging and supplying composition containing pharmacologically active substance to animal tissue in controllable manner |
US5028428A (en) | 1988-08-09 | 1991-07-02 | Estee Lauder Inc. | Anti-irritant and desensitizing compositions and methods of their use |
US5248501A (en) | 1988-11-22 | 1993-09-28 | Parnell Pharmaceuticals | Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith |
AU1058797A (en) | 1995-11-22 | 1997-06-11 | Bristol-Myers Squibb Company | Treatment with calcium channel blockers for drug-induced hypersensitivity |
JP4743947B2 (en) * | 2000-10-05 | 2011-08-10 | 株式会社明治 | Lipid metabolism improving composition |
-
2005
- 2005-07-18 US US11/183,495 patent/US7399493B2/en not_active Expired - Fee Related
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950481A (en) * | 1984-09-21 | 1990-08-21 | Innofinance Altalanos Innovacios Penzintezet | Skin regenerating and hydrating cosmetic compositions and process for the preparation of the active ingredient |
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
US5252604A (en) * | 1992-07-10 | 1993-10-12 | Hoffmann-La Roche Inc. | Compositions of retinoic acids and tocopherol for prevention of dermatitis |
US5843979A (en) * | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
US5516793A (en) * | 1993-04-26 | 1996-05-14 | Avon Products, Inc. | Use of ascorbic acid to reduce irritation of topically applied active ingredients |
US5618577A (en) * | 1993-07-02 | 1997-04-08 | Congoleum Corporation | Release coating |
US5393526A (en) * | 1994-02-07 | 1995-02-28 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic compositions |
US5545407A (en) * | 1994-10-20 | 1996-08-13 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith using benzoyl peroxide and tocopherol esters |
US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US5912010A (en) * | 1994-11-22 | 1999-06-15 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US6423747B1 (en) * | 1994-12-13 | 2002-07-23 | Beiersdorf Ag | Cosmetic and dermatological preparations with flavonoids |
US20010022978A1 (en) * | 1994-12-28 | 2001-09-20 | Lacharriere Olivier De | Cosmetic, pharmaceutical or dermatological composition comprising a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist |
US5716987A (en) * | 1996-06-21 | 1998-02-10 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US6670395B1 (en) * | 1996-06-21 | 2003-12-30 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120164185A1 (en) * | 2010-12-28 | 2012-06-28 | Barry Markman | Oral nutrient or medicant carrier having increased surface area and absorption rate |
US20140316175A1 (en) * | 2011-12-31 | 2014-10-23 | Chenguang Biotech Group Co. Ltd. | Process for Extracting Lycopene |
US9434886B2 (en) * | 2011-12-31 | 2016-09-06 | Chenguang Biotech Group Co. Ltd. | Process for extracting lycopene |
US11744793B2 (en) * | 2016-04-08 | 2023-09-05 | Givaudan Italia S.p.A. | Cosmetic compositions for protection against air pollutants |
Also Published As
Publication number | Publication date |
---|---|
US7399493B2 (en) | 2008-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2562140C2 (en) | Composition and method of treating signs of skin aging | |
EP2613763B1 (en) | Cosmetic compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation | |
CN111712305B (en) | Kapok extract and cosmetic, pharmaceutical or dermatological composition containing same | |
CN108697610A (en) | Passionflower seed extract and cosmetics, drug or dermatological compositions comprising it | |
US20180000722A1 (en) | Preparation for protecting against extrinsic and intrinsic skin aging | |
EP2613764B1 (en) | Bioactive compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation | |
WO2012172199A1 (en) | Composition based on camellia japonica and polygonum hydropiper for protecting the skin | |
US20070042026A1 (en) | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions | |
JP4577868B2 (en) | Matrix metalloprotease activity inhibitor | |
KR101390465B1 (en) | Method for Preparing Paeonia lactiflora Extracts Containing Taxifolin-3-glucoside and Cosmetic Composition Containing Preparing Paeonia lactiflora Extracts | |
Kanlayavattanakul et al. | Anti-aging of phenolic-rich Acanthus ebracteatus Vahl. extracts | |
WO2012081370A1 (en) | Inhibitor of activity of endothelin, and skin whitening agent | |
KR102529107B1 (en) | Cosmetic composition for scalp dandruff suppression and hair strengthening, containing Aurea Helianthus leaves as an active ingredient | |
JP2011504922A (en) | Cosmetic or dermatological composition containing orchid extract and cosmetic care method using the composition | |
KR20080036302A (en) | Preparation method of tea extract and cosmetic composition for preventing skin aging and anti-wrinkle containing tea extract as an active ingredient | |
CA3065334C (en) | Skin care applications of extracellular metabolites from bacillus coagulans | |
US7399493B2 (en) | Anti-irritant botanicals | |
CN114502139B (en) | Moringa oleifera seed extract enriched in 2, 5-diformylfuran, method for obtaining same and use thereof in cosmetic compositions | |
KR20100018139A (en) | A skin-care agent containing sedum sarmentosum extracts and lipoic acid-peg conjugated compounds | |
KR101389211B1 (en) | Cosmetic Composition Comprising Nano Capsule Containing Extract of Camellia Sinensis, Curcuma Longa, Magnolia Obovata and Aralia Continentalis and Manufacturing Method Thereof | |
KR20160021371A (en) | Anti-inflammation and Anti-aging composition for skin external application comprising Narcissus tazetta Cell Culture Extract and Methods for preparing the Same | |
WO2008032331A1 (en) | Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof | |
US20230060288A1 (en) | Murraya koenigii extract and use thereof in cosmetics | |
KR101558186B1 (en) | Cosmetic composition containing fox bead extract | |
Wille et al. | Isolation and elucidation of Antiirritant and Antimicrobial Bioactives Derived from Plant sources and from human sebum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20160715 |